...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: you won’t see anyone buying this

" So anyone that may be part of this group may feel that if they load up in these time frames they may find themselves under some scrunty"

Should of added - they will only be concerned & limit or stop their buying if the rumour is in fact ture.Dont believe it would be worth the risk to them imo.Mind you greed has sunk many a ship.

Share
New Message
Please login to post a reply